NCT01310205 - Extension Study SCI-SCV-HCV-P2-001: Long-Term FU in Subj Who Opt for Retreatment With Peg-INF and RBV After Completing Treatment in HCV | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

August 31, 2010

Primary Completion Date

March 31, 2012

Study Completion Date

March 31, 2012

Conditions

Chronic Hepatitis C

Interventions

DRUG

SCV-07

This is an extension of ongoing study SCI-SCV-HCV-P2-001. Subjects will be invited to participate in this extension study if they complete treatment in study SCI-SCV-HCV-P2-001 and are eligible for retreatment with peg-IFN and RBV

Trial Locations (4)

20307

Walter Reed Army Medical Center, Washington

45267

University of Cincinnati Medical Center, Cincinnati

92803

AGMG Clinical Research, Anaheim

Unknown

Univ of Louisville Med/Dental Complex, Louisville